(Q35733259)

10 August 2017

1 reference

title

CD34 cell dose and chronic graft-versus-host disease after human leukocyte antigen-matched sibling hematopoietic stem cell transplantation (English)

1 reference

10 August 2017

1 reference

Rainer Storb

1 reference

10 August 2017

Marco Mielcarek

1 reference

10 August 2017

Beverly Torok-Storb

1 reference

10 August 2017

Shelly Heimfeld

1 reference

10 August 2017

Paul J Martin

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

27-34

1 reference

Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000151103

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000151103

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000151103

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000151103

Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000151103

Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000151103

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000151103

CD34 stem cell dose and development of extensive chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000151103

10.1080/1042819031000151103

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference